Moderna, Inc. — Director's Dealing 2020

Jun 4, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Moderna, Inc. (MRNA)
CIK: 0001682852
Period of Report: 2020-06-02

Reporting Person: Zaks Tal Zvi (Chief Medical Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-06-02	Common Stock	M	11467	$12.21	Acquired	11467	Direct
2020-06-02	Common Stock	M	47737	$14.22	Acquired	59204	Direct
2020-06-02	Common Stock	M	39752	$19.15	Acquired	98956	Direct
2020-06-02	Common Stock	S	3174	$56.28	Disposed	95782	Direct
2020-06-02	Common Stock	S	12797	$57.15	Disposed	82985	Direct
2020-06-02	Common Stock	S	48079	$58.13	Disposed	34906	Direct
2020-06-02	Common Stock	S	30381	$59.11	Disposed	4525	Direct
2020-06-02	Common Stock	S	4525	$59.81	Disposed	0	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-06-02	Stock Option (Right to Buy)	$12.21	M	11467	Disposed	2027-02-23	Common Stock (11467)	Direct
2020-06-02	Stock Option (Right to Buy)	$14.22	M	47737	Disposed	2028-02-28	Common Stock (47737)	Direct
2020-06-02	Stock Option (Right to Buy)	$19.15	M	39752	Disposed	2026-08-10	Common Stock (39752)	Direct

Footnotes

F1: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 13, 2020.

F2: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $55.60 to $56.57. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F3: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $56.61 to $57.61. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F4: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $57.65 to $58.65. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F5: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $58.67 to $59.67. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F6: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $59.69 to $59.94. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F7: 25% of this option vested and became exercisable on February 22, 2018 with the remainder vesting in 12 equal quarterly installments thereafter.

F8: 25% of this option vested and became exercisable on February 27, 2019 with the remainder vesting in 12 equal quarterly installments thereafter.

F9: This option is fully vested and exercisable.